Literature DB >> 24012099

Ovarian Brenner tumour: a morphologic and immunohistochemical analysis suggesting an origin from fallopian tube epithelium.

Elisabetta Kuhn1, Ayse Ayhan, Ie-Ming Shih, Jeffrey D Seidman, Robert J Kurman.   

Abstract

BACKGROUND: Brenner tumours (BTs), like other epithelial ovarian tumours, are thought to develop from the ovarian surface epithelium. AIM AND METHODS: We hypothesised that BTs arise from transitional metaplasia near the tuboperitoneal junction which, when embedded in the ovary as Walthard cell nests, may progress to BTs. The aim of this study was to validate this hypothesis by a morphologic and immunohistochemical (IHC) analysis.
RESULTS: The IHC analysis revealed that fallopian tube secretory cells, transitional metaplasia, Walthard cell nests and the epithelial component of BTs shared a similar IHC profile, consistently expressing AKR1C3 (an enzyme involved in androgen biosynthesis) and androgen receptor, but not calretinin. The tumour stromal cells that immediately surrounded the epithelial nests showed strong expression of calretinin, inhibin and steroidogenic factor 1 (markers of steroidogenic cells) in the majority of BTs. Using a highly sensitive immunofluorescent staining method, we detected small groups of cilia in transitional metaplasia and Walthard cell nests, multifocal stretches of cilia and/or ciliated vacuoles in benign BTs and well-developed cilia in atypical proliferative BTs.
CONCLUSIONS: Our findings suggest a tubal origin of BTs through transitional metaplasia and Walthard cell nests, based on their anatomic proximity, similar IHC profile and the presence of cilia. In addition, we hypothesise a role of androgenic stimulation in the pathogenesis of BT, based on the IHC staining pattern of calretinin, inhibin and steroidogenic factor 1 expressed in the luteinised stromal cells surrounding the epithelial nests of the tumours, and AKR1C3 and androgen receptor expressed in both the epithelial and stromal components.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Brenner tumour; Histogenesis; Metaplasia; Ovarian tumour; Pathogenesis; Transitional; Tuboperitoneal junction

Mesh:

Substances:

Year:  2013        PMID: 24012099     DOI: 10.1016/j.ejca.2013.08.011

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  13 in total

1.  The pathogenesis of atypical proliferative Brenner tumor: an immunohistochemical and molecular genetic analysis.

Authors:  Elisabetta Kuhn; Ayse Ayhan; Ie-Ming Shih; Jeffrey D Seidman; Robert J Kurman
Journal:  Mod Pathol       Date:  2013-07-26       Impact factor: 7.842

2.  Clonality analysis of combined Brenner and mucinous tumours of the ovary reveals their monoclonal origin.

Authors:  Yihong Wang; Ren-chin Wu; Lauren Ende Shwartz; Lisa Haley; Ming-tse Lin; Ie-ming Shih; Robert J Kurman
Journal:  J Pathol       Date:  2015-07-23       Impact factor: 7.996

3.  Molecular Genetic Analysis of Ovarian Brenner Tumors and Associated Mucinous Epithelial Neoplasms: High Variant Concordance and Identification of Mutually Exclusive RAS Driver Mutations and MYC Amplification.

Authors:  Laura J Tafe; Kristen E Muller; Guruprasad Ananda; Talia Mitchell; Vanessa Spotlow; Sara E Patterson; Gregory J Tsongalis; Susan M Mockus
Journal:  Am J Pathol       Date:  2016-01-18       Impact factor: 4.307

Review 4.  Ovarian Cancers: Genetic Abnormalities, Tumor Heterogeneity and Progression, Clonal Evolution and Cancer Stem Cells.

Authors:  Ugo Testa; Eleonora Petrucci; Luca Pasquini; Germana Castelli; Elvira Pelosi
Journal:  Medicines (Basel)       Date:  2018-02-01

Review 5.  [Grading of gynecological tumors : Current aspects].

Authors:  L-C Horn; D Mayr; C E Brambs; J Einenkel; I Sändig; K Schierle
Journal:  Pathologe       Date:  2016-07       Impact factor: 1.011

6.  Borderline Brenner tumor of the ovary: a case report with immunohistochemical and molecular study.

Authors:  Rossella De Cecio; Monica Cantile; Francesca Collina; Laura Marra; Clemente Santonastaso; Cono Scaffa; Gerardo Botti; Nunzia Simona Losito
Journal:  J Ovarian Res       Date:  2014-10-29       Impact factor: 4.234

7.  Malignant Brenner tumor associated with a germline BRCA2 mutation.

Authors:  Michael D Toboni; Haller J Smith; Sarah E Dilley; Lea Novak; Charles A Leath
Journal:  Gynecol Oncol Rep       Date:  2017-05-31

8.  Protective effects of vitamin D3 on fimbrial cells exposed to catalytic iron damage.

Authors:  Francesca Uberti; Vera Morsanuto; Debora Lattuada; Barbara Colciaghi; Andrea Cochis; Alessandro Bulfoni; Paola Colombo; Giorgio Bolis; Claudio Molinari
Journal:  J Ovarian Res       Date:  2016-06-17       Impact factor: 4.234

9.  CCNE1 amplification and centrosome number abnormality in serous tubal intraepithelial carcinoma: further evidence supporting its role as a precursor of ovarian high-grade serous carcinoma.

Authors:  Elisabetta Kuhn; Tian-Li Wang; Kai Doberstein; Asli Bahadirli-Talbott; Ayse Ayhan; Ann Smith Sehdev; Ronny Drapkin; Robert J Kurman; Ie-Ming Shih
Journal:  Mod Pathol       Date:  2016-07-22       Impact factor: 7.842

10.  A case of a vaginal Brenner tumor without a gland mimicking a borderline tumor: unusual morphology and diagnostic pitfalls.

Authors:  Qin Zhang; Can Tian; Kun Wang; Qi Xin; Yan Shen; Chuan-Shan Zhang; Zhe Ma
Journal:  J Int Med Res       Date:  2020-08       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.